Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL6229697

COc1ccc(C[S+](C)C)cc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.43
CA12 O43570 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
CA5A P35218 1/20 0.42
CA9 Q16790 1/20 0.42
CA14 Q9ULX7 1/20 0.42
PKM P14618 1/20 0.42
APLNR P35414 1/20 0.41
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
EGFR P00533 1/20 0.41
ERBB2 P04626 1/20 0.41
ACHE P22303 4/20 0.40
PTPRZ1 P23471 1/20 0.40
BMP1 P13497 1/20 0.39
BCHE P06276 1/20 0.39
HSD11B1 P28845 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL31221559 0.86 BCHE (0.47) CA12CA1CA2CA9ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL31221554 0.82 KCNH2 (0.42) KCNH2CA12CA1CA2CA5A
Trifluoromethanesulfonic Acid SCHEMBL1455736 0.81 PKM (0.46) KCNH2CA12CA1CA2CA5A
Trifluoromethanesulfonic Acid SCHEMBL31221579 0.81 ACHE (0.43) CA1CA2ALDH1A1SMN1; SMN2ACHE
Trifluoromethanesulfonic Acid SCHEMBL5828491 0.80 GPR3 (0.43) KCNH2CA1CA2CA5ACA9
Trifluoromethanesulfonic Acid SCHEMBL31221600 0.80 LOXL2 (0.46) CA12CA1CA2CA9CA14
Trifluoromethanesulfonic Acid SCHEMBL31221635 0.79 CA2 (0.41) CA1CA2ALDH1A1SMN1; SMN2ACHE
Trifluoromethanesulfonic Acid SCHEMBL5146818 0.79 KCNH2 (0.46) KCNH2CA12CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL565735 0.77 HTT (0.43) KCNH2ALDH1A1EGFRERBB2ACHE
Trifluoromethanesulfonic Acid SCHEMBL31221626 0.77 CYP19A1 (0.42) CA12CA1CA2CA9ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119192042-A Direct cross-coupling method of benzyl sulfonium salt and thiosulfate 南京工业大学 2024-12-27 CN claimed
EP-1516229-A2 PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS AZ Electronic Materials USA Corp. (US) 2005-03-23 EP claimed
US-20030235782-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds MERCK PATENT GMBH (DE) 2003-12-25 US claimed
WO-2003107093-A2 PHOTORESIST COMPOSITION FOR DEEP ULTRAVIOLET LITHOGRAPHY COMPRISING A MIXTURE OF PHOTOACTIVE COMPOUNDS CLARIANT INTERNATIONAL LTD (CH) 2003-12-24 WO claimed
CN-119192042-A Direct cross-coupling method of benzyl sulfonium salt and thiosulfate 南京工业大学 2024-12-27 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030235782-A1 Photoresist composition for deep ultraviolet lithography comprising a mixture of photoactive compounds SUN2, UROD, ERCC1 KCNH2 1940/4885CA12 932/4885CA1 458/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.